Revvity has received FDA clearance for its total testosterone automated ChLIA via its Immunodiagnostic Systems subsidiary.The post Revvity secures FDA...
Osel, together with Imperial College London’s Clinical Trials Unit and March of Dimes, has launched the Phase IIb FLIP-2 trial,...
Pfizer has received EC approval to expand the Hympavzi indication to treat haemophilia A or B with inhibitors in patients...
Roche has secured CE mark for the Elecsys pTau217 blood test, developed alongside Eli Lilly, for detecting Alzheimer's disease pathology.The...
Alkermes has reported positive top line data from the Phase III REVITALYZ study, assessing the investigational use of extended-release Lumryz...
Isomorphic Labs has secured $2.1bn in funding to expedite its transition from developing AI models to deploying them on a...
HeartBeam has commenced a pilot study to evaluate its on-demand 12-lead ECG patch in patients with suspected coronary artery disease.The...
Inhibrx Biosciences has reported positive interim data from the Phase II segment of its HexAgon study assessing INBRX-106 in treatment-naïve,...
Partner Therapeutics has received FDA approval for Bizengri to treat adults with advanced, unresectable or metastatic cholangiocarcinoma harbouring an NRG1...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.